TherapeuticsMD
TXMD
TXMD
38 hedge funds and large institutions have $5.49M invested in TherapeuticsMD in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-5
Holders Change %
-11.63%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
11
Closed
8
Calls
$31K
Puts
$7K
Net Calls
+$24K
Net Calls Change
+$8K
Top Buyers
| 1 |
CC
Clearline Capital
New York
|
+$163K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$23.1K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.05K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.1K |
Top Sellers
| 1 |
CHAM
Clear Harbor Asset Management
Stamford,
Connecticut
|
-$59.1K |
| 2 |
PCG
Prosperity Consulting Group
Owings Mills,
Maryland
|
-$56.1K |
| 3 |
Renaissance Technologies
New York
|
-$31K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$23.3K |
| 5 |
BlackRock
New York
|
-$17.1K |
